Clinical trial
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
NCT00337519 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00337519 |
|---|---|
| Title | Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia |
| Official title | Chemo-Immunotherapy With Allogeneic Blood Stem Cell Transplantation in Patients With Chronic Lymphocytic Leukemia (Study #02) |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | University Hospital Carl Gustav Carus Deutsche Klinik fuer Diagnostik |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | allogeneic stem cell transplantation, Alemtuzumab |
| Enrollment | 82 |
| Start date | Jan 1, 2003 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jun 16, 2006 |
| Last update posted | Jan 29, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: